Diagnostic Accuracy of an “Amended” Insulin–Glucose Ratio for the Biochemical Diagnosis of Insulinomas
- 4 December 2012
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 157 (11) , 767-775
Abstract
Recent biochemical diagnostic guidelines for insulinomas require demonstration of hypoglycemia with inappropriately elevated (nonsuppressed) insulin, C-peptide, or proinsulin, but these criteria may overlap with those in patients without insulinomas. Use of an "amended" insulin-glucose ratio that accounts for the normal variation in insulin secretion according to prevailing glycemia may improve diagnostic accuracy. To compare the diagnostic accuracy of current diagnostic guideline criteria with the amended insulin-glucose ratio in patients with a suspected insulinoma. Retrospective cohort study. 2 specialized university departments in Germany. 114 patients with suspected hypoglycemia over 10 years having diagnostic prolonged fasts. Glucose, insulin, C-peptide, and the amended insulin-glucose ratio were measured during and at discontinuation of prolonged fasts. Of 114 patients who were evaluated, 49 had surgical resection of histologically confirmed insulinomas. Insulinoma was excluded in 65 patients; follow-up for a mean of 10 years (range, 0 to 16 years) showed no progressively severe hypoglycemic events or diagnoses of insulinoma. Patients with insulinoma had lower glucose levels and higher insulin and C-peptide levels overall than did control patients at the end of prolonged fasts, but there was considerable overlap. The amended insulin-glucose ratio correctly identified 48 of 49 patients with insulinoma and excluded the diagnosis in 64 of 65 control patients, resulting in positive and negative predictive values of 0.98 (95% CI, 0.89 to 1.00) and 0.99 (CI, 0.92 to 1.00), respectively, compared with 0.75 (CI, 0.63 to 0.85) and 0.98 (CI, 0.89 to 1.00), respectively, for glucose, insulin, and C-peptide concentration criteria. The study had a retrospective design, no proinsulin concentrations were available, and a nonspecific insulin immunoassay (crossreactive with proinsulin) was used. The amended insulin-glucose ratio showed improved diagnostic accuracy over established criteria that use glucose, insulin, and C-peptide concentrations. None.Keywords
This publication has 22 references indexed in Scilit:
- A hyperinsulinaemic, sequentially eu‐ and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinomaEuropean Journal of Clinical Investigation, 1997
- Reversibility of Unawareness of Hypoglycemia in Patients with InsulinomasNew England Journal of Medicine, 1993
- Localization of Pancreatic Endocrine Tumors by Endoscopic UltrasonographyNew England Journal of Medicine, 1992
- Clinical pathology of endocrine tumors of the pancreasDigestive Diseases and Sciences, 1991
- Hypoglykämische und hyperinsulinämische Clamp-Technik zur Ermittlung des Sekretionsverhaltens von InsulinomenDMW - Deutsche Medizinische Wochenschrift, 1988
- Feedback Inhibition of Insulin Secretion by Insulin: Relation to the Hyperinsulinemia of ObesityNew England Journal of Medicine, 1982
- Stabilization of Plasma Glucose during FastingNew England Journal of Medicine, 1974
- Insulinoma: Natural History and DiagnosisClinics in Gastroenterology, 1974
- Biochemical and morphological investigations of 30 human insulinomasDiabetologia, 1973
- Proinsulin Secretion by a Pancreatic Beta-Cell AdenomaNew England Journal of Medicine, 1970